Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

PaperCitations, authors & open-access status

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 75 citations, 2022 year and gold oa status.

75
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Linping Gu
Author
PARP inhibition in cancer therapy
Topic
PARP inhibition in cancer therapy
Topic
Cancer Immunotherapy and Biomarkers
Topic
DNA Repair Mechanisms
Topic
470M+ articles · free account